A New Long-acting Methylphenidate (Concerta)
Methylphenidate (Ritalin, and others) is now available in a new extended-release formulation (Concerta--Alza) for treatment of attention deficit/hyperactivity disorder (ADHD)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A New Long-acting Methylphenidate (Concerta)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1086
Article Code: 1086b
Date: September 4, 2000
Volume: 42
Pages: 80-81
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1086
Article Code: 1086b
Date: September 4, 2000
Volume: 42
Pages: 80-81
Add this downloadable, electronic article to your cart (U.S. English version only) Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.